Intellia
Intellia
Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Gene Editing
CRISPR Technology
Cell Engineering
Bioinformatics
Drug Development
Open roles at Intellia
0 open roles
No open positions at this time
Closed positions
4 positions
Our Culture
Remote
Closed 6 months ago
ONE Intellia
Remote
Closed 6 months ago
Join Us
Remote
Closed 6 months ago
Careers
Remote
Closed 6 months ago
Products and services
CR
CRISPR/Cas9 Gene Editing Platform
Gene Editing Technology
NT
NTLA-2001
Gene Editing Therapy
NT
NTLA-3001
Gene Editing Therapy
EX
Ex Vivo Cell Engineering
Cell Engineering Service
NT
NTLA-2002
Gene Editing Therapy
NE
Neurological Disease Programs
Gene Editing Therapy
PR
Primary Hyperoxaluria Program
Gene Editing Therapy
MO
Modular CRISPR Platform
Platform Technology
AS
ASGR1 Program
Gene Editing Therapy
IN
In Vivo Gene Editing Services
Gene Editing Service
LI
Lipid Nanoparticle Delivery System
Drug Delivery Technology
NTLA-5001
Cell Therapy
IM
Immunology Pipeline
Therapeutic Pipeline
NTLA-2003
Gene Editing Therapy
Asgard Platform
Platform Technology
LI
Lipid Nanoparticle Platform
Technology Platform
ON
Oncology Cell Therapies
Cell Therapy
Engineered Cell Medicines
Cell Therapy
CR
CRISPR Platform Technology
Technology Platform
Similar companies
Editas Medicine
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Cambridge, Middlesex County
201-500 employees
Public
Valuation $1.2B
1 open jobs
Pfizer
We integrate environment, health, and safety (EHS) into how we run our business to ensure that management of risk and regulatory compliance are overseen at…
New York City, New York
10,001+ employees
Public
Valuation $280B
285 open jobs
Xaira
AI for drug discovery
San Francisco, CA
51-200 employees
Private
Valuation 2.1B
Merck
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Rahway, New Jersey
10,001+ employees
Public
Valuation $208B
279 open jobs
Bluebird Bio
Develops gene therapies for severe genetic disorders.
Cambridge, Middlesex County
201-500 employees
Public
Valuation $350M
Latest updates
All
X
News
HN
YouTube
H.C. Wainwright reiterates Intellia stock rating on FDA review progress - Investing.com
Investing.com
News
·
Today
Citizens reiterates Intellia stock rating on FDA priority review - Investing.com
Investing.com
News
·
Today
Intellia's 'Lonvo-Z' Enters FDA Priority Review — Bids to Become World's First In Vivo CRISPR Therapy - finance.biggo.com
finance.biggo.com
News
·
Today
Intellia Announces FDA Acceptance of BLA for Lonvo-z with PDUFA Date March 10, 2027 - TradingView
TradingView
News
·
Yesterday
Intellia’s one-shot CRISPR therapy gets March 2027 FDA decision date - allsci.com
allsci.com
News
·
Yesterday
Show 15 more
Total Views
4
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
2.7
2 reviews
Work-life balance
3.0
Compensation
3.0
Culture
2.0
Career
2.5
Management
1.5
25%
Recommend to a friend
Pros
Potential for meaningful medical impact
Working on innovative treatments
Opportunity to help patients with rare diseases
Cons
Poor management decisions
Unfair layoff practices
Favoritism in promotions
Salary Ranges
47 data points
Mid/L4
1 reports
-
total per year
Base
$165,000
Stock
-
Contact and location